This inventor holds 3 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignee: Fudan University. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020
Title: Innovations of Inventor Ting Tang
Introduction
Ting Tang is a notable inventor based in Shanghai, China. He has made significant contributions to the field of chemical pharmaceuticals, holding a total of 3 patents. His work focuses on developing innovative compounds that have potential therapeutic applications.
Latest Patents
Ting Tang's latest patents include a biaryl urea derivative or salt thereof and its preparation process and use. This invention discloses a biaryl urea RORγt inhibitor, specifically relating to a biaryl urea derivative that exhibits RORγt inhibiting activity. The patent also details a pharmaceutical composition comprising the compound, which can be used for treating RORγt-related diseases. Another significant patent involves a biaryl compound, its preparation method, and its use. This invention pertains to biaryl derivatives with RORγt activation activity, which can effectively activate the RORγt protein receptor. This activation promotes the differentiation of Th17 cells and increases the production of IL-17, making it useful as an immune modulator for treating various cancers or viral infection-related diseases.
Career Highlights
Ting Tang is affiliated with Fudan University, where he conducts his research and development work. His academic background and research endeavors have positioned him as a key figure in his field.
Collaborations
Ting Tang collaborates with several esteemed colleagues, including YongHui Wang and Yafei Huang, who contribute to his research initiatives.
Conclusion
Ting Tang's innovative work in the pharmaceutical field demonstrates his commitment to advancing medical science through his patented inventions. His contributions have the potential to impact the treatment of various diseases significantly.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
